Create your page here
Latest News for: Pharmaceutical sources
Edit
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024
ACCESSWIRE 29 Oct 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / October 29, 2024 / Amphastar Pharmaceuticals, Inc ... Bill Peters Chief Financial Officer (909) 476-3416 SOURCE. Amphastar Pharmaceuticals, Inc.
Edit
New survey finds people are becoming more aware of Biodiversity hazards
News India Times 29 Oct 2024
The UEBT has been setting standards for good supply and sources of ingredients in beauty, food, natural pharmaceuticals, flavors and fragrances, and herbs and spices.
Edit
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
ACCESSWIRE 28 Oct 2024
ZURICH, SWITZERLAND / ACCESSWIRE / October 28, 2024 / NLS Pharmaceutics Ltd ... "We are pleased to report that Nasdaq has recognized our full compliance with their listing requirements," said Alex Zwyer, Chief Executive Officer of NLS Pharmaceutics.
Edit
MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain
Pharmiweb 28 Oct 2024
Edit
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy ...
ACCESSWIRE 27 Oct 2024
To report SUSPECTED ADVERSE REACTIONS, contact Salix Pharmaceuticals at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch ... Salix Pharmaceuticals View the original press release on accesswire.com ....
Edit
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Pharmiweb 27 Oct 2024
To report SUSPECTED ADVERSE REACTIONS, contact Salix Pharmaceuticals at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch ... SOURCE. Salix Pharmaceuticals.
Edit
Iowa legislative candidates send mixed messages on water quality
The Gazette Cedar Rapids 27 Oct 2024
Edit
Billionaires, Newspapers and Politics – A Dangerous Mix
The Wrap 27 Oct 2024
Free speech ... Do better WaPo ... They sift through facts, track down sources, try to identify misinformation – all under enormous pressure ... government, and Soon-Shiong’s main source of wealth is his pharmaceutical research which depends on federal approval.
Edit
AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced
AOL 25 Oct 2024
AstraZeneca has said it may cut jobs at its UK operation if the government enforces a global push to make companies share profits derived from nature’s genetic codes, multiple sources have told the Guardian.
Edit
Industrial Sugar Market 2023-2028 : Latest Trends, Key Segments, Growth Drivers, Opportunities, and Leading players
GetNews 25 Oct 2024
Industrial Sugar Market by Type (White Sugar, Brown Sugar, & Liquid Sugar), Application (Dairy Products, Bakery Products, Confectionery, Beverages, & Pharmaceuticals), Source (Sugarcane & Sugar Beet) and Region - Global Forecast to 2028.
Edit
CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia
Pharmiweb 24 Oct 2024
BEIJING, CHINA / ACCESSWIRE / October 24, 2024 / CASI Pharmaceuticals, Inc ... About CASI Pharmaceuticals. CASI Pharmaceuticals, Inc ... CASI Pharmaceuticals, Inc ... SOURCE. CASI Pharmaceuticals, Inc.
Edit
Phytosterols Market Analysis: Opportunities and Challenges for Industry Stakeholders
GetNews 24 Oct 2024
Phytosterols Market by Composition (Beta-Sitosterol, Campesterol, Stigmasterol), Application (Food & Beverages, Pharmaceutical, Cosmetics & Personal Care Products, and Feed), Form (Dry, Liquid), Source and Region - Global Forecast to 2028.
Edit
How To Find the Best Biotech Penny Stocks Right Now
PennyStocks 23 Oct 2024
Investors should focus on biotech companies that have recently secured funding from reputable sources, such as venture capital firms, institutional investors, or strategic partnerships with larger pharmaceutical companies.
Edit
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market ...
ACCESSWIRE 23 Oct 2024
HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc ... About CNS Pharmaceuticals, Inc ... Investor Relations Contact JTC Team, LLC Jenene Thomas 908-824-0775 CNSP@jtcir.com SOURCE.
- 1
- 2
- Next page »
Article Search
Most Viewed
AP / Iranian Army
AP / Evan Vucci
Creative Commons / Daniel X. O'Neil https://creativecommons.org/licenses/by/2.0/deed.en
AP / Abdel Kareem Hana, File
AP / Philippine Coast Guard via AP, File
AP / John Minchillo, File
AP / Charles Sykes
AP / Juliana Yamada
AP / Antonio Calanni
Creative Commons / Raph_PH
